Anzalone Christopher Richard

Average Profitability
<0.0001%
Insider Buys Quantity
4
Insider Buys Sum
$865,960.00
Insider Sells Quantity
35
Insider Sells Sum
$83.6M

Insider Activity of Anzalone Christopher Richard

According to the SEC Form 4 filings, Anzalone Christopher Richard, being in a position of

  1. Chief Executive Officer at Arrowhead Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 79451 share for $2.51M,
    over all time since 2008-08-22, has bought 400000 shares for $865,960, and sold 2861414 shares for $83.6M.

The largest purchase of all time was on 2008-08-22 and amounted to 328000 shares of Arrowhead Pharmaceuticals, Inc. for $628,120.

The largest sale of all time was on 2022-02-11 and amounted to 146388 shares of Arrowhead Pharmaceuticals, Inc. for $7.6M.

Biography of Anzalone Christopher Richard

No biography is available at this moment.

2024-01-31SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
57,499
0.0525%
$32.35$1.86M-23.02%
2024-01-02SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
9,952
0.0093%
$31.01$308,637-18.85%
2023-12-20SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
12,000
0.0114%
$28.54$342,480-10.54%
2023-10-25SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
24,338
0.0229%
$24.21$589,223+7.82%
2023-09-18SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
57,755
0.0539%
$28.12$1.62M-6.47%
2023-05-04SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
50,000
0.0462%
$39.52$1.98M-27.22%
2023-05-03SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
54,928
0.0501%
$39.14$2.15M-27.41%
2022-02-11SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
146,388
0.1421%
$51.91$7.6M-28.88%
2021-12-15SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
60,000
0.0551%
$67.56$4.05M-41.37%
2021-10-22SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
50,000
0.0475%
$65.63$3.28M-33.38%
2021-10-20SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
15,000
0.0142%
$66.23$993,450-34.07%
2020-12-09SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
38,676
0.0377%
$69.06$2.67M+1.23%
2020-12-08SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
16,324
0.0158%
$67.97$1.11M+2.17%
2020-10-23SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
100,000
0.0962%
$58.21$5.82M+16.1%
2020-08-13SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
50,000
0.0481%
$41.35$2.07M+59.66%
2020-06-25SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
100,000
0.0902%
$38.81$3.88M+59.39%
2019-12-24SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
83,333
0.0844%
$63.50$5.29M-33.3%
2019-12-13SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
83,333
0.0862%
$66.73$5.56M-35.21%
2019-12-12SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
100,000
0.1033%
$67.50$6.75M-36.04%
2019-12-03SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Executive Officer
12,033
0.0111%
$61.58$740,952-37.29%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.